Acid-suppressive Medications and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus

被引：0
|
作者：
Kim, Gwang Ha [1 ,2 ]
机构：
[1] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan 602739, South Korea
[2] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea
来源：
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY | 2015年 / 21卷 / 02期
关键词：
PROTON PUMP INHIBITORS; GASTRIN; CANCER;
D O I：
10.5056/jnm15004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：288 / 289
页数：2
相关论文
共 50 条
  • [21] CHARACTERIZATION OF ESOPHAGEAL MICROBIOTA IN PATIENTS WITH BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
    Lopetuso, L. R.
    Severgnini, M.
    Ianiro, G.
    Pecere, S.
    Boskoski, I.
    Quaranta, G.
    Camboni, T.
    Scaldaferri, F.
    Riccioni, M.
    Masucci, L.
    Consolandi, C.
    Gasbarrini, A.
    Costamagna, G.
    Cammarota, G.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E107 - E107
  • [22] Esophageal Adenocarcinoma in a First Degree Relative Increases the Risk for Progression to Esophageal Adenocarcinoma in Patients With Barrett's Esophagus
    Tofani, Christina
    Gandhi, Kunjal
    Spataro, Joseph
    Yoo, Joseph
    Murphy, Megan
    Mohan, Neena
    Daitch, Zachary
    Shah, Apeksha
    Janowski, Raymond
    Dabbish, Noreen
    Keith, Scott
    Kastenberg, David
    Coben, Robert M.
    Cohen, Sidney
    Infantolino, Anthony
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S170 - S170
  • [23] Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus
    Tofani, Christina J.
    Gandhi, Kunjal
    Spataro, Joseph
    Yoo, Joseph
    Murphy, Megan
    Mohan, Neena
    Daitch, Zachary
    Shah, Apeksha
    Janowski, Raymond
    Huntley, Colin
    Dabbish, Nooreen
    Keith, Scott
    Coben, Robert
    Cohen, Sidney
    Kastenberg, David
    Infantolino, Anthony
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (02) : 225 - 229
  • [24] Chemoprevention of Esophageal Adenocarcinoma among Patients with Barrett's Esophagus
    Masclee, Gwen M. C.
    Coloma, Preci M.
    Kuipers, Ernst J.
    Sturkenboom, Miriam C. J. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 324 - 324
  • [25] Focus on Barrett's esophagus and esophageal adenocarcinoma
    Paulson, TG
    Reid, BJ
    CANCER CELL, 2004, 6 (01) : 11 - 16
  • [26] Chemoprevention in Barrett's esophagus and esophageal adenocarcinoma
    Alkhayyat, Motasem
    Kumar, Prabhat
    Sanaka, Krishna O.
    Thota, Prashanthi N.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [27] Advances in Barrett's esophagus and esophageal adenocarcinoma
    Shaheen, NJ
    GASTROENTEROLOGY, 2005, 128 (06) : 1554 - 1566
  • [28] Familial Barrett’s Esophagus and Esophageal Adenocarcinoma
    Joel Gabre
    Amitabh Chak
    Anil Rustgi
    Current Treatment Options in Gastroenterology, 2020, 18 (4) : 616 - 622
  • [29] Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers
    Grady, William M.
    Yu, Ming
    Markowitz, Sanford D.
    Chak, Amitabh
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (12) : 2486 - 2494
  • [30] MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma
    Kan, Takatsugu
    Meltzer, Stephen J.
    CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (06) : 727 - 732
12345